A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

The Ministry of Public Health has verified the identification of a new coronavirus, HKU5-CoV-2, by a laboratory in China, stating that no human infections have been reported to date.

Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...

The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...

Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price increased by equities researchers at Barclays from ...

The Ministry of Public Health yesterday confirmed the discovery of a new coronavirus, HKU5-CoV-2, by a laboratory in China but said no human infections have been recorded as yet.Dr Opas Karnkawinpong, ...

Pediatrician Dr. Mario Yanakiev has warned that a second flu wave is expected to follow the peak of the first.

Vir Biotechnology (NASDAQ:VIR – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC ...

Last winter, one Brisbane mother saw two of her children admitted to different hospitals as beds ran out. This year, ...